Speakers

Sort by
Newest
Trending
1-22 of 22
Filter
Richard Harris
Founder at Great Health and Wellness
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Jorge A. Escudero
Pharmacist at CBD Apothecary
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Christina Sasser
CEO at Vital Leaf
adele, agriculture, android (operating system), ann arbor, michigan, attention, ayurveda, bank of america, big data, brand, california, canada, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis sativa, china, chinese herbology, craft brewery and microbrewery, customer, debate, dose (biochemistry), drug, dvd, flower, food, food and drug administration, goal, grocery store, heat, heavy metal music, hemp, herb, ice cream, illinois, medication, michael jackson, microphone, mirror, molecule, muhammad ali, nanotechnology, new york city, news, nutraceutical, ohio, percentage, pesticide, pharmaceutical industry, placebo, psalms, reggae, retail, runway, scientific method, seed, snow removal, spotify, stress (biology), taste, thalidomide, traditional chinese medicine, united states, united states department of agriculture, water, whole foods market, wine, wood
Joseph Nowell
Owner/Compounding Pharmacist at The Fresh Pharmacy
big data, brand, cannabidiol, cannabinoid, cannabis (drug), cannabis sativa, craft brewery and microbrewery, customer, dose (biochemistry), food, goal, herb, medication, mirror, molecule, placebo, scientific method, stress (biology), taste, thalidomide, water, whole foods market, wine, wood
Brian Beckley
Managing Editor at Marijuana Venture
big data, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabinoid, cannabis (drug), cannabis sativa, chromatography, clinical trial, craft brewery and microbrewery, crisis management, customer, dietary supplement, dose (biochemistry), end-user, food, fraud, goal, herb, high-performance liquid chromatography, laboratory, marketplace, medication, mining, mirror, molecule, national institutes of health, placebo, reason, research, right to know, scientific method, stress (biology), taste, thalidomide, the end-user, thin-layer chromatography, warranty, water, whole foods market, wine, wood
Kayla Fioravanti
Business Owner at Ology Essentials
aromatherapy, bank, big data, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis sativa, clinical trial, craft brewery and microbrewery, crop insurance, curriculum, customer, dose (biochemistry), evidence-based medicine, finance, food, food and drug administration, goal, herb, medical cannabis, medical prescription, medication, mirror, molecule, organized crime, pain management, payment, pharmaceutical industry, placebo, placebo-controlled study, prescription drug, scientific method, stress (biology), taste, tetrahydrocannabinol, thalidomide, water, whole foods market, wine, wood
Jake Black
Chief Scientific Officer at Treehouse Biotech
accuracy and precision, analgesic, anesthesia, animal testing, aromatherapy, attention, big data, biochemistry, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, carbon dioxide, carboxylic acid, cell (biology), certificate of analysis, certification, chemistry, chemotherapy, chromatography, circulatory system, cocaine, court, data, dietary supplement, dose (biochemistry), drug overdose, drug rehabilitation, drug test, electric battery, electronic cigarette, endocannabinoid system, entourage effect, enzyme, essential oil, ethanol, food, food and drug administration, fungus, gas chromatography, glyphosate, greenhouse gas, hemp, herb, herbal medicine, inquiry, international organization for standardization, iso/iec 17025, kashrut, life, lipid bilayer, major depressive disorder, mass, measurement uncertainty, medical cannabis, medication, mercury (element), mood (psychology), mood disorder, natural product, nutrient, odor, olfaction, opiate, opioid, over-the-counter drug, pain, pain management, parts-per notation, perfume, personalized medicine, pesticide, pesticide residue, pharmaceutical industry, pharmacology, placebo, prescription drug, product liability, propagation of uncertainty, protein structure, protein structures, protein-protein interaction, protein–protein interaction, quantification (science), regulatory compliance, reliability engineering, reputation, research, science, solvent, stress (biology), substance dependence, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinol acid, traceability, uncertainty, united states pharmacopeia, validity (statistics), vaporizer (inhalation device), vitamin, water, whole foods market
Rod Kight
Attorney at Kight on Cannabis
analgesic, anesthesia, big data, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chase bank, circulatory system, cvs health, data, dose (biochemistry), escrow, food, franchising, futures contract, general counsel, globalization, hemp, herbal medicine, jpmorgan chase, law firm, major depressive disorder, medical cannabis, medical prescription, medication, mergers and acquisitions, mind, mood (psychology), mood disorder, natural product, nutrient, pain, paypal, pharmacology, placebo, supply chain, target corporation, tetrahydrocannabinol, vitamin
Jenelle Kim
CEO at Progressive Care (RXMD)
advertising, analgesic, analytics, anesthesia, aromaticity, behavior, big data, brand, buyer (fashion), cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chromium, circulatory system, consumer behavior, data, dietary supplement, digital display advertising, dose (biochemistry), entourage effect, epilepsy, facebook, food, food and drug administration, goal, good manufacturing practice, hemp, herbal medicine, inspection, inventory, lead time, ligand (biochemistry), limonene, major depressive disorder, masters tournament, medical cannabis, medication, medicine, mind, mood (psychology), mood disorder, natural product, nutrient, organic certification, packaging and labeling, pain, pay-per-click, pharmaceutical industry, pharmacology, placebo, pricing, private label, quality management, quality management system, question, reality, reason, retail, route of administration, startup company, synergy, target audience, tetrahydrocannabinol, tiger woods, time, traditional chinese medicine, vitamin, vitamin c, warehouse, whole foods market
Peter Calfee
CEO at Gofire
adele, analgesic, android (operating system), anesthesia, ann arbor, michigan, bank of america, big data, california, canada, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, data, debate, dose (biochemistry), dvd, heavy metal music, herbal medicine, ice cream, illinois, major depressive disorder, medical cannabis, medication, michael jackson, microphone, mood (psychology), mood disorder, muhammad ali, nanotechnology, natural product, new york city, news, nutrient, ohio, pain, pharmacology, placebo, psalms, reggae, snow removal, spotify, tetrahydrocannabinol, united states, vitamin
Leah Maurer
Co-Owner/COO at The Weed Blog
analgesic, anesthesia, big data, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, data, dose (biochemistry), herbal medicine, major depressive disorder, medical cannabis, medication, mood (psychology), mood disorder, natural product, nutrient, pain, pharmacology, placebo, tetrahydrocannabinol, vitamin
Karyemaitre Aliffe
Charlotte's Web
addiction, alternative medicine, analgesic, anesthesia, antihypertensive drug, benzodiazepine, big data, brand, caffeine, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, craft brewery and microbrewery, crohn's disease, customer, data, depression (mood), diarrhea, dose (biochemistry), drug, entourage effect, food, gastrointestinal disease, general surgery, goal, herb, herbal medicine, heroin, ileostomy, inflammatory bowel disease, major depressive disorder, mechanism of action, medical cannabis, medical prescription, medication, microwave, mirror, molecule, mood (psychology), mood disorder, natural product, nutrient, pain, pharmacology, phytochemistry, placebo, psychoactive drug, recreational drug use, route of administration, scientific method, sedative, social rejection, stress (biology), substance abuse, substance dependence, taste, terminal illness, tetrahydrocannabinol, tetraodontidae, thalidomide, therapeutic index, ulcerative colitis, vitamin, water, whole foods market, wine, wood
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
William Fisher
Board Chairman at Diverse Biotech
appetite, aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), chemotherapy, clinical trial, dementia, dietary supplement, direct-to-consumer advertising, dose (biochemistry), drug development, endocannabinoid system, fibromyalgia, first, pass effect, food and drug administration, gastrointestinal tract, headache, hemp, in vitro, inflammation, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, opioid epidemic in the united states, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, route of administration, sensitivity and specificity, steve jobs, synthetic cannabinoids, tetrahydrocannabinol, toxicity
Tristan Watkins
Chief Science Officer (CSO) at LucidMood
23andme, adolescence, aromatherapy, aromaticity, bicycle, biotechnology, brand, budtender, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chromium, concept, creativity, curveball, dietary supplement, disease, dose (biochemistry), drink, electronic cigarette, engineer, entourage effect, epilepsy, food, food and drug administration, genetics, good manufacturing practice, hemp, herbal medicine, inflammation, insomnia, ligand (biochemistry), limonene, market (economics), medical cannabis, medication, medicine, memory, mind, pharmaceutical industry, placebo, questionnaire, race (human categorization), relaxation (psychology), reverse engineering, route of administration, science, sedative, sense, slider (baseball), synergy, terpene, tetrahydrocannabinol, time, traditional chinese medicine, washington (state), zolpidem
1